What is the KLOW Stack?

The KLOW Stack is a 4-peptide combination of KPV, BPC-157, TB-500, and GHK-Cu. It is the most comprehensive anti-inflammation, tissue repair, and skin rejuvenation peptide stack available. KPV provides molecular-level anti-inflammation via NF-κB inhibition, BPC-157 drives localized tissue repair and angiogenesis, TB-500 promotes systemic cell migration and healing, and GHK-Cu stimulates collagen synthesis and extracellular matrix remodeling. The name "KLOW" is derived from the combination of KPV with the existing GLOW Stack (GHK-Cu + BPC-157 + TB-500).

How is the KLOW Stack different from the GLOW Stack?

The GLOW Stack (GHK-Cu + BPC-157 + TB-500) focuses on skin rejuvenation, collagen synthesis, and tissue repair through three complementary mechanisms. The KLOW Stack adds KPV, a potent anti-inflammatory tripeptide derived from alpha-MSH that directly inhibits NF-κB signaling — the master switch of inflammation. This makes the KLOW Stack significantly more effective for chronic inflammatory conditions, autoimmune-related tissue damage, and situations where active inflammation is preventing tissue healing and skin recovery.

How is the KLOW Stack different from the Total Recovery Stack (BPC-157 + KPV + TB-500)?

The Total Recovery Stack focuses on inflammation reduction and systemic healing without a skin rejuvenation component. The KLOW Stack adds GHK-Cu, which introduces copper peptide-driven collagen synthesis, extracellular matrix remodeling, and potent antioxidant activity. This makes the KLOW Stack better for users who want comprehensive inflammation control AND visible skin improvement, anti-aging, wound healing with minimal scarring, and overall tissue regeneration.

Can I take all four peptides at the same time?

Yes. KPV and BPC-157 can be taken together (especially orally for gut-focused protocols). GHK-Cu and TB-500 can be injected in the same session. Use separate syringes for each injectable peptide — do not mix different peptides in the same syringe, especially GHK-Cu, as the copper ion could interact with other peptides in solution. For SubQ protocols, you can inject all peptides in one session at different injection sites.

Should I use oral or injectable for this stack?

It depends on your primary goals. For gut inflammation (IBD, IBS, leaky gut, colitis), oral BPC-157 (500–750 mcg) and oral KPV (200–500 mcg) on an empty stomach are preferred, with TB-500 and GHK-Cu injected SubQ. For systemic inflammation with skin focus, SubQ injection of all four peptides provides better bioavailability. Many users combine both routes: oral BPC-157 and KPV for gut healing plus SubQ TB-500 and GHK-Cu for systemic repair and skin benefits.

How long does the KLOW Stack take to show results?

Anti-inflammatory effects from KPV and healing effects from BPC-157 and TB-500 are often noticeable within 1–2 weeks. Skin improvements from GHK-Cu take longer because collagen remodeling is a slow biological process — most users report visible texture and tone improvements at 4–6 weeks, with continued improvement through 8–12 weeks. For chronic inflammatory conditions, allow 4–6 weeks for significant progress. Full protocol duration is 8–12 weeks.

Is the KLOW Stack safe?

All four peptides have demonstrated favorable safety profiles in animal studies and community use. GHK-Cu is a naturally occurring human peptide, and KPV is a fragment of the naturally occurring alpha-MSH hormone. However, none of the four peptides is FDA-approved for human use, and controlled human clinical trial data is limited — particularly for the 4-peptide combination. Common side effects are mild: injection site irritation, occasional nausea, and transient fatigue. KPV's potent anti-inflammatory activity warrants monitoring for signs of immunosuppression with prolonged use. Consult a healthcare provider before use.

How many vials do I need for a full KLOW Stack cycle?

For an 8-week cycle with the standard protocol: KPV at 500 mcg daily requires 28 mg total (vial count depends on supplier sizing, typically three to six vials). BPC-157 at 250 mcg twice daily requires 28 mg total (six 5 mg vials). TB-500 at 2.5 mg twice weekly for 4 weeks (loading) then once weekly for 4 weeks (maintenance) requires 30 mg total (six 5 mg vials). GHK-Cu at 2 mg daily requires 112 mg total (eleven to twelve 10 mg vials). The KLOW Stack is the most peptide-intensive stack due to four daily or semi-daily compounds.

Is the KLOW Stack banned in sports?

BPC-157 and TB-500 are both prohibited by the World Anti-Doping Agency (WADA) for competitive athletes. KPV is derived from alpha-MSH, and melanocortin peptides fall under WADA prohibited categories. GHK-Cu is not currently explicitly listed on the WADA prohibited list, but athletes subject to anti-doping testing should avoid the entire stack due to the BPC-157, TB-500, and KPV components.

Can I start with fewer peptides and add more later?

Yes. Common stepping-stone approaches include: (1) Start with BPC-157 + TB-500 (Wolverine Stack) for basic healing, then add KPV for inflammation and GHK-Cu for skin. (2) Start with BPC-157 + KPV (Gut Healer Stack) for gut-focused protocols, then add TB-500 for systemic healing and GHK-Cu for skin. (3) Start with the GLOW Stack (GHK-Cu + BPC-157 + TB-500), then add KPV for enhanced anti-inflammatory coverage. You can add peptides at any point in the cycle without restarting.

Can I use topical GHK-Cu instead of injectable in this stack?

Topical GHK-Cu is effective for surface-level skin improvements such as fine lines, skin texture, and pigmentation. However, topical application does not achieve meaningful systemic levels needed for joint, tendon, or deep tissue benefits. For the full KLOW Stack benefit, subcutaneous injection of GHK-Cu at 1–2 mg daily is recommended. Some users combine both: injectable GHK-Cu for systemic effects and a topical copper peptide serum for additional facial skin benefits.

Can I add other peptides to the KLOW Stack?

The KLOW Stack is already a comprehensive 4-peptide combination. Adding more peptides increases complexity, cost, and injection burden significantly. If you want growth hormone support, CJC-1295 + Ipamorelin can be added but requires careful timing around meals. For antimicrobial support in gut protocols, LL-37 is sometimes used alongside. However, most users find the 4-peptide KLOW Stack provides sufficient coverage for inflammation, healing, and skin goals without additional compounds.

KPV + BPC-157 + TB-500 + GHK-Cu Stack Guide

The KLOW Stack — the ultimate 4-peptide combination for anti-inflammation, tissue repair, and skin rejuvenation. Complete dosing protocols, timing, cycling, and safety for KPV, BPC-157, TB-500, and GHK-Cu together.

Compiled by PeptideWiki Editorial Team

Stack Overview

The KPV + BPC-157 + TB-500 + GHK-Cu combination — known as the “KLOW Stack” — is the most comprehensive peptide stack for simultaneously targeting chronic inflammation, tissue repair, and skin rejuvenation. It combines the proven GLOW Stack with KPV's potent molecular anti-inflammatory activity, creating a 4-peptide protocol that addresses healing from every angle: molecular inflammation control, localized tissue repair, systemic cell migration, and collagen matrix remodeling.

Key Characteristics:

4-peptide stack — KPV (alpha-MSH fragment) + BPC-157 (Body Protection Compound-157) + TB-500 (Thymosin Beta-4 fragment) + GHK-Cu (copper tripeptide-1)
Primary goal — chronic inflammation reduction, gut healing, systemic tissue repair, skin rejuvenation, collagen synthesis, anti-aging, and autoimmune support
Quad-mechanism synergy — KPV inhibits NF-κB inflammatory signaling; BPC-157 promotes local angiogenesis and growth factors; TB-500 drives systemic cell migration and anti-inflammation; GHK-Cu remodels the extracellular matrix and activates collagen
Experience level — intermediate to advanced; recommended for users with prior peptide experience due to the 4-compound protocol and daily injection commitment
Typical cycle — 8–12 weeks with TB-500 loading phase in the first 4 weeks
Administration — subcutaneous injection for all four peptides; KPV and BPC-157 can also be taken orally for gut-focused protocols; GHK-Cu can be applied topically for surface skin benefits

Use our Peptide Dosage Calculator to calculate exact doses for all four peptides based on your vial sizes and reconstitution volumes.

Important: KPV, BPC-157, TB-500, and GHK-Cu are not FDA-approved for human use. All four are classified as research peptides. All dosing information in this guide is derived from animal studies and community protocols — not from human clinical trials. Consult a healthcare provider before using any research peptide.

Why This Stack Works

The KLOW Stack is effective because it combines four peptides that operate through fundamentally different but complementary mechanisms. Rather than addressing one or two pathways, this combination targets inflammation and repair from four distinct angles: molecular inflammation control, localized repair, systemic healing, and matrix remodeling.

KPV: The Inflammation Controller

NF-κB inhibition: directly suppresses the NF-κB signaling pathway — the master switch that activates pro-inflammatory cytokines including TNF-α, IL-6, and IL-1β
Anti-inflammatory cascade: reduces the production of inflammatory mediators at the molecular level, addressing the root cause of chronic inflammation rather than just symptoms
Gut mucosal protection: demonstrated anti-inflammatory activity in colitis models, protecting the intestinal mucosa from inflammatory damage
Immune modulation: derived from alpha-MSH, a naturally occurring hormone involved in melanocortin receptor-mediated immune regulation

BPC-157: The Local Repair Agent

Angiogenesis: upregulates VEGF (vascular endothelial growth factor), promoting formation of new blood vessels at the injury site to deliver nutrients and oxygen
Growth factor expression: increases EGF, FGF, and other factors that stimulate cell proliferation and tissue remodeling
Nitric oxide modulation: interacts with the NO system to regulate blood flow, inflammation, and repair signaling at the injury site
Gut healing: promotes mucosal healing and gut barrier integrity, synergizing with KPV's anti-inflammatory action for comprehensive gut repair

TB-500: The Systemic Healer

Actin regulation: sequesters G-actin to promote cell migration, allowing repair cells to reach damaged tissue faster
Anti-inflammatory: reduces systemic inflammation, creating a more favorable environment for healing throughout the body
Flexibility and remodeling: promotes tissue remodeling and reduces scar tissue formation, improving functional recovery
Blood cell production: stimulates new blood cell formation and improves endothelial cell function

GHK-Cu: The Matrix Remodeler

Collagen synthesis: directly stimulates production of collagen types I, III, and V in fibroblasts, rebuilding the structural foundation of skin, tendons, and connective tissue
Extracellular matrix remodeling: activates matrix metalloproteinases (MMPs) that break down damaged tissue while simultaneously promoting deposition of new, organized matrix components
Antioxidant and anti-inflammatory: one of the most potent natural antioxidants, neutralizing free radicals and reducing oxidative damage that accelerates tissue aging
Immune cell attraction: attracts macrophages and mast cells to sites of damage, coordinating the immune response for efficient wound healing

The Quad Synergy

KPV shuts down the inflammatory cascade at the molecular level, creating an environment where repair can proceed without ongoing inflammatory interference. BPC-157 creates favorable local healing conditions with new blood vessels, growth factors, and enhanced nitric oxide signaling. TB-500 reduces systemic inflammation and promotes the migration of repair cells toward these enriched environments. GHK-Cu rebuilds the structural framework — collagen matrix, connective tissue scaffolding, and skin architecture. The result is faster, more complete tissue repair with visible skin improvements and sustained inflammation control that no 2- or 3-peptide stack can match.

Evidence note: Each peptide has independent research supporting its mechanisms. GHK-Cu has been studied since the 1970s, BPC-157 and TB-500 have extensive animal research, and KPV has demonstrated anti-inflammatory activity in colitis models. The synergistic benefit of combining all four is primarily supported by community experience and mechanistic reasoning rather than controlled human trials of the specific combination.

Individual Peptide Breakdown

Each peptide in this stack has a dedicated dosage guide with complete individual protocols. Here is a summary of each peptide's role in the KLOW Stack.

KPV (Alpha-MSH Fragment)

Type: Tripeptide fragment (Lys-Pro-Val) of alpha-melanocyte stimulating hormone
Origin: Derived from the C-terminal end of alpha-MSH, a naturally occurring immune-modulating hormone
Role in stack: Molecular anti-inflammation via NF-κB inhibition, gut mucosal protection, immune modulation
Route: Subcutaneous injection or oral
Frequency: Once daily

BPC-157 (Body Protection Compound-157)

Type: Synthetic pentadecapeptide (15 amino acids)
Origin: Derived from human gastric juice proteins
Role in stack: Localized tissue repair, angiogenesis, growth factor upregulation, gut healing
Route: Subcutaneous injection (near injury) or oral
Frequency: Once or twice daily

Full BPC-157 Dosage Guide →

TB-500 (Thymosin Beta-4 Fragment)

Type: Synthetic peptide fragment of Thymosin Beta-4 (43 amino acids)
Origin: Based on naturally occurring thymic peptide involved in cell migration
Role in stack: Systemic anti-inflammation, cell migration, tissue remodeling
Route: Subcutaneous injection
Frequency: Twice weekly (loading), once weekly (maintenance)

Full TB-500 Dosage Guide →

GHK-Cu (Copper Tripeptide-1)

Type: Naturally occurring copper-binding tripeptide (3 amino acids + Cu2+)
Origin: Found naturally in human plasma, saliva, and urine; levels decline with age
Role in stack: Collagen synthesis, extracellular matrix remodeling, antioxidant protection
Route: Subcutaneous injection or topical
Frequency: Once daily

Full GHK-Cu Dosage Guide →

Dosing Protocol

The KLOW Stack uses different dosing frequencies for each peptide. KPV, BPC-157, and GHK-Cu are used daily, while TB-500 follows a loading/maintenance schedule with less frequent injections.

Standard Protocol

Compound	Dose	Frequency	Route	Notes
KPV	250–500 mcg	Once daily	SubQ or oral	Oral for gut-focused protocols; SubQ for systemic anti-inflammation
BPC-157	250 mcg	Once or twice daily	SubQ (near injury) or oral	Consistent daily dosing throughout the entire cycle
TB-500	2–2.5 mg	Twice weekly (loading)	SubQ (abdomen or near injury)	Loading phase: weeks 1–4 to build systemic levels
TB-500	2–2.5 mg	Once weekly (maintenance)	SubQ (abdomen or near injury)	Maintenance phase: weeks 5–8+ after loading
GHK-Cu	1–2 mg	Once daily	SubQ (abdomen or target area)	Start at 1 mg and increase to 2 mg if well tolerated

Gut-Focused Protocol

Compound	Dose	Frequency	Route	Notes
KPV	200–500 mcg	Once daily	Oral (empty stomach)	Direct delivery to GI mucosa for gut inflammation
BPC-157	500–750 mcg	Once daily	Oral (empty stomach)	Higher oral dose for direct gut mucosal healing
TB-500	2 mg	Twice weekly	SubQ	4-week loading, then once weekly maintenance
GHK-Cu	1 mg	Once daily	SubQ + optional topical	Lower dose for supporting tissue regeneration alongside gut repair

Protocol selection: The standard protocol is recommended for users with systemic inflammation, musculoskeletal injuries, and skin concerns. The gut-focused protocol prioritizes oral delivery of KPV and BPC-157 for direct GI action, with injectable TB-500 and GHK-Cu for systemic and structural support. Both protocols can be customized based on individual response.

Calculate Your Doses

All four peptides are supplied as lyophilized powder and need reconstitution with bacteriostatic water. The dose you draw depends on the concentration after reconstitution.

KPV — 5 mg Vial

Vial size: 5 mg (5,000 mcg)
Bacteriostatic water: 2 mL
Concentration: 5,000 ÷ 2 = 2,500 mcg/mL
500 mcg dose = 0.2 mL = 20 units on insulin syringe
Doses per vial: 10 doses (at 500 mcg)

BPC-157 — 5 mg Vial

Vial size: 5 mg (5,000 mcg)
Bacteriostatic water: 2 mL
Concentration: 5,000 ÷ 2 = 2,500 mcg/mL
250 mcg dose = 0.1 mL = 10 units on insulin syringe
Doses per vial: 20 doses

TB-500 — 5 mg Vial

Vial size: 5 mg (5,000 mcg)
Bacteriostatic water: 1 mL
Concentration: 5,000 ÷ 1 = 5,000 mcg/mL
2.5 mg dose = 0.5 mL = 50 units on insulin syringe
Doses per vial: 2 doses

GHK-Cu — 10 mg Vial

Vial size: 10 mg (10,000 mcg)
Bacteriostatic water: 2 mL
Concentration: 10,000 ÷ 2 = 5,000 mcg/mL (5 mg/mL)
2 mg dose = 0.4 mL = 40 units on insulin syringe
Doses per vial: 5 doses (at 2 mg)

Skip the Math — Use Our

Enter your vial size, water volume, and desired dose for each peptide — get instant calculations with zero manual math.

Reconstitution Guide

All four peptides follow the same reconstitution process. Reconstitute each vial separately with bacteriostatic water.

Peptide	Vial Size	Bac Water	Concentration	Standard Dose Draw
KPV	5 mg	2 mL	2,500 mcg/mL	20 units (0.2 mL) for 500 mcg
BPC-157	5 mg	2 mL	2,500 mcg/mL	10 units (0.1 mL) for 250 mcg
TB-500	5 mg	1 mL	5,000 mcg/mL	50 units (0.5 mL) for 2.5 mg
GHK-Cu	10 mg	2 mL	5 mg/mL	40 units (0.4 mL) for 2 mg

Wash Hands & Prepare Workspace

Wash hands thoroughly. Lay out supplies: peptide vials, bacteriostatic water, insulin syringes, and alcohol swabs on a clean surface.

Swab All Vial Stoppers

Remove plastic caps and swab the rubber stoppers of each peptide vial and the bacteriostatic water vial with alcohol pads. Let air-dry for 10–15 seconds.

Add Water to Each Peptide Vial

Draw the appropriate volume of bacteriostatic water for each vial. Insert needle and direct the stream down the inside glass wall — never squirt directly onto the powder. Release slowly. Reconstitute each vial separately.

Dissolve Gently

Let each vial sit for 1–2 minutes, then gently swirl or roll between palms until fully dissolved. GHK-Cu solution may have a faint blue tint from the copper — this is normal. All solutions should be clear. Never shake.

Label & Refrigerate

Write the reconstitution date and concentration on each vial. Store all vials refrigerated at 2–8°C. Use within 28–30 days.

For a detailed visual walkthrough, see our Reconstitution Guide.

Timing & Daily Schedule

The four peptides in this stack have different dosing frequencies. Here is how a typical week looks during the loading phase (weeks 1–4):

Day	KPV	BPC-157	TB-500	GHK-Cu
Monday	500 mcg	250 mcg AM + 250 mcg PM	2.5 mg	2 mg
Tuesday	500 mcg	250 mcg AM + 250 mcg PM	—	2 mg
Wednesday	500 mcg	250 mcg AM + 250 mcg PM	—	2 mg
Thursday	500 mcg	250 mcg AM + 250 mcg PM	2.5 mg	2 mg
Friday	500 mcg	250 mcg AM + 250 mcg PM	—	2 mg
Saturday	500 mcg	250 mcg AM + 250 mcg PM	—	2 mg
Sunday	500 mcg	250 mcg AM + 250 mcg PM	—	2 mg

Timing Notes

KPV: Once daily at a consistent time. For oral dosing, take on an empty stomach (30 minutes before food). For SubQ, no strict timing requirements.
BPC-157: Split doses 8–12 hours apart (e.g., 8 AM and 8 PM) when dosing twice daily. For oral dosing, take on an empty stomach.
TB-500: Can be injected at any time of day. Space injections 3–4 days apart during loading (e.g., Monday/Thursday or Tuesday/Friday).
GHK-Cu: Once daily at a consistent time. Morning is most common. No strict meal or fasting requirements for injectable dosing.
Same session: All injectable peptides can be administered in the same session using separate syringes. No waiting period between injections.
Injection sites: KPV in the abdomen for systemic coverage; BPC-157 near the injury or target tissue; TB-500 works systemically from any SubQ site; GHK-Cu in the abdomen or near the target area.

Maintenance phase (weeks 5–8+): KPV, BPC-157, and GHK-Cu continue daily as before. TB-500 drops to once weekly — pick one consistent day (e.g., every Monday).

Cycling & Duration

The KLOW Stack is typically run for 8–12 weeks. The extended duration compared to simpler stacks accounts for GHK-Cu's slow collagen remodeling timeline and KPV's role in managing chronic inflammatory conditions.

Phase	Duration	KPV	BPC-157	TB-500	GHK-Cu
Loading	Weeks 1–4	250–500 mcg daily	250 mcg 1–2x/day	2–2.5 mg 2x/week	1–2 mg daily
Active	Weeks 5–8	250–500 mcg daily	250 mcg 1–2x/day	2–2.5 mg 1x/week	1–2 mg daily
Extended (optional)	Weeks 9–12	250 mcg daily	250 mcg 1x/day	2 mg 1x/week	1 mg daily
Break	4–6 weeks off	None	None	None	None
Repeat (if needed)	8–12 weeks	Resume daily	Resume daily	Resume with loading	Resume daily

When to Extend the Cycle

Chronic inflammatory conditions: Autoimmune disorders, long-standing gut inflammation, or systemic inflammatory conditions may require 10–12 weeks for meaningful resolution
Significant skin damage or scarring: Deep scars, sun damage, or post-surgical skin may need the extended phase for meaningful collagen remodeling
Combined gut and skin goals: When addressing both internal inflammation and external skin rejuvenation, the longer timeline ensures both processes complete

Why Take a Break?

The break period serves to: (1) assess improvements without peptide support and confirm that changes are structural, (2) allow the body to consolidate tissue remodeling, (3) prevent potential immune system imbalance from prolonged KPV-driven NF-κB suppression, and (4) reduce unnecessary exposure to four research compounds when therapeutic goals may have been achieved. A longer break (4–6 weeks) is recommended for the KLOW Stack compared to simpler stacks because of KPV's immune modulation effects.

Safety, Side Effects & Contraindications

Safety profile: All four peptides in the KLOW Stack have demonstrated favorable safety profiles in animal studies and community use. GHK-Cu is a naturally occurring human peptide, and KPV is derived from the naturally occurring alpha-MSH hormone. However, human clinical trial data for all four peptides (especially in combination) is limited, and long-term safety has not been formally evaluated.

Common Side Effects

Injection site redness, soreness, or minor swelling — the most common report across all four peptides
GHK-Cu injection site may show mild irritation or warmth due to the copper component
Mild nausea — more common with BPC-157, usually resolves within days
Transient fatigue or lethargy — occasionally reported
Headache — may occur in the first few days of use
Faint blue tint at GHK-Cu injection site — rare, related to copper content, resolves quickly
Mild flushing or warmth — occasionally reported with KPV due to its melanocortin receptor activity

Contraindications

Active cancer or history of cancer: All four peptides promote aspects of tissue growth. BPC-157 promotes angiogenesis, TB-500 drives cell migration, GHK-Cu stimulates cell proliferation, and KPV modulates immune surveillance. These effects could theoretically support tumor growth or reduce immunosurveillance. Avoid use with active malignancies.
Wilson's disease or copper metabolism disorders: GHK-Cu introduces additional copper into the body. Individuals with Wilson's disease or other copper accumulation disorders should not use GHK-Cu.
Active or chronic infections: KPV's potent anti-inflammatory and immune-modulating effects may impair the body's ability to fight active infections. Resolve infections before starting the KLOW Stack.
Pregnancy and breastfeeding: No safety data exists for any of these peptides during pregnancy or nursing. Avoid entirely.
Active infections at injection site: Do not inject through infected, inflamed, or broken skin.
Anticoagulant therapy: BPC-157 interacts with the NO system and may affect platelet function. Consult your healthcare provider if taking blood thinners.

Stack-Specific Safety Notes

Immune modulation awareness: The KLOW Stack combines two anti-inflammatory peptides (KPV and TB-500) with tissue-growth-promoting peptides (BPC-157 and GHK-Cu). The combined anti-inflammatory effect is stronger than any individual component. Monitor for signs of immunosuppression with prolonged use.
Increased angiogenic and proliferative load: The four-peptide combination promotes tissue growth through multiple pathways simultaneously. While beneficial for repair, this reinforces the theoretical concern about use with active cancers.
Copper accumulation: At recommended doses (1–2 mg/day), GHK-Cu contributes a very small amount of copper. This is not a concern for healthy individuals, but those on copper-containing supplements should be aware of cumulative intake.
Separate syringes: Use dedicated syringes for each peptide. The copper ion in GHK-Cu could potentially interact with other peptides if mixed in solution.

Regulatory status: KPV, BPC-157, TB-500, and GHK-Cu are not FDA-approved for human use. All four are classified as research peptides. BPC-157, TB-500, and KPV are prohibited by WADA for competitive athletes. Regulations vary by jurisdiction — verify your local laws before purchasing.

Common KLOW Stack Mistakes

Avoid these common errors to get the most out of your KPV + BPC-157 + TB-500 + GHK-Cu protocol:

Using topical GHK-Cu and expecting systemic effects

Topical copper peptide serums improve surface skin quality but do not penetrate deeply enough for joint, tendon, or systemic tissue repair. For deep tissue and systemic benefits in the KLOW Stack, subcutaneous injection at 1–2 mg daily is required.

Skipping the TB-500 loading phase

TB-500 requires a loading phase (2–2.5 mg twice weekly for 4 weeks) to build up systemic levels. Starting at the maintenance dose provides inadequate initial tissue saturation and delays the systemic healing benefit that complements the other three peptides.

Not using the oral route for gut-focused protocols

When targeting gut inflammation (IBD, leaky gut, colitis), oral administration of BPC-157 and KPV delivers the peptides directly to the GI mucosa. SubQ injection provides systemic benefits but misses the direct local action on gut tissue. For gut-focused goals, oral dosing of BPC-157 and KPV on an empty stomach is essential.

Mixing all four peptides in the same syringe

Stability and compatibility data for combining KPV, BPC-157, TB-500, and GHK-Cu in one syringe is not established. The copper ion in GHK-Cu could potentially interact with other peptides in solution. Use separate syringes for each peptide to ensure integrity and accurate dosing.

Expecting quick skin results from GHK-Cu

Collagen synthesis and extracellular matrix remodeling are slow biological processes. GHK-Cu stimulates these pathways, but visible skin improvements typically require 4–6 weeks of consistent use. Healing effects from BPC-157, KPV, and TB-500 appear faster, but skin rejuvenation requires patience.

Stopping the protocol too early

Symptom improvement after 2–3 weeks does not mean the underlying inflammation or tissue damage is resolved. Inflammatory tissue remodeling takes 6–8 weeks minimum, and collagen turnover in the skin takes approximately the same period. Complete the full cycle duration before assessing overall results.

Not monitoring for immunosuppression with prolonged KPV use

KPV is a potent anti-inflammatory that modulates immune signaling pathways via NF-κB inhibition. Extended use beyond 8–12 weeks without breaks may lead to excessive dampening of the immune response. Watch for increased frequency of minor infections, slow wound healing, or unusual fatigue as potential signs.

Not refrigerating reconstituted vials

All four peptides must be refrigerated at 2–8°C after reconstitution. GHK-Cu in particular is sensitive to degradation at room temperature. Use reconstituted vials within 28–30 days. This applies equally to KPV, BPC-157, TB-500, and GHK-Cu.

Taking excessive GHK-Cu doses for faster skin results

GHK-Cu follows a dose-response curve where higher is not necessarily better. Doses above 2–3 mg daily have not been shown to provide additional benefit in community reports and may increase injection site irritation. Stick to the 1–2 mg daily range and let the 4-peptide synergy work over time.

Frequently Asked Questions

Key Takeaways

The KLOW Stack (KPV + BPC-157 + TB-500 + GHK-Cu) is the most comprehensive anti-inflammation, healing, and skin rejuvenation peptide combination — addressing inflammation control (KPV), localized repair (BPC-157), systemic healing (TB-500), and collagen remodeling (GHK-Cu)
KPV dose: 250–500 mcg once daily — oral for gut-focused protocols, SubQ for systemic anti-inflammation
BPC-157 dose: 250 mcg SubQ once or twice daily near the injury or target area throughout the cycle
TB-500 dose: 2–2.5 mg SubQ twice weekly (loading) then once weekly (maintenance)
GHK-Cu dose: 1–2 mg SubQ once daily throughout the entire cycle for collagen synthesis and matrix remodeling
TB-500 requires a loading phase (weeks 1–4) to build systemic levels before dropping to maintenance
Use separate syringes for each peptide — do not mix any of the four in the same syringe
Be patient with skin results — collagen remodeling takes 4–6 weeks to become visible, with continued improvement through 8–12 weeks
Typical cycle: 8–12 weeks with 4–6 weeks off before repeating if needed
Refrigerate all reconstituted vials at 2–8°C and use within 28–30 days
Monitor for immunosuppression with prolonged KPV use — NF-κB inhibition can dampen immune response over time
Avoid with active cancer, copper metabolism disorders, or active infections — all four peptides promote tissue growth and/or modulate immune function
None of these peptides is FDA-approved for human use. All are classified as research peptides. BPC-157, TB-500, and KPV are banned by WADA.

This article is for educational and informational purposes only. KPV, BPC-157, TB-500, and GHK-Cu are not approved by the FDA for human use and are classified as research peptides. They are not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare provider before using any research peptide, especially if you have pre-existing medical conditions, are taking medications, or are pregnant or nursing. See our Medical Disclaimer.

References

Brzoska T, et al. “Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects.” Endocr Rev. 2008;29(5):581-602.
Kannengiesser K, et al. “Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease.” Inflamm Bowel Dis. 2008;14(3):324-331.
Sikiric P, et al. “Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.” Curr Pharm Des. 2018;24(18):1990-2001.
Staresinic M, et al. “Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon.” J Orthop Res. 2003;21(6):976-983.
Goldstein AL, et al. “Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues.” Trends Mol Med. 2005;11(9):421-429.
Malinda KM, et al. “Thymosin beta4 accelerates wound healing.” J Invest Dermatol. 1999;113(3):364-368.
Pickart L, Margolina A. “Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data.” Int J Mol Sci. 2018;19(7):1987.
Pickart L. “The human tri-peptide GHK and tissue remodeling.” J Biomater Sci Polym Ed. 2008;19(8):969-988.
Pickart L, et al. “GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration.” Biomed Res Int. 2015;2015:648108.
Seiwerth S, et al. “BPC 157's effect on healing.” J Physiol Paris. 2014;108(2-3):51-59.
Getting SJ, et al. “Molecular determinants of the anti-inflammatory actions of the melanocortin peptides.” Pharmacol Ther. 2006;111(1):1-15.

Next Steps

Continue your research with these resources.

GLOW Stack Guide

The 3-peptide GHK-Cu + BPC-157 + TB-500 stack for skin and tissue repair without the KPV anti-inflammatory component.

Read Guide

Total Recovery Stack Guide

The 3-peptide BPC-157 + KPV + TB-500 stack for inflammation and healing without the GHK-Cu skin rejuvenation component.